Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.Journal of affective disorders · 2026-05-01Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.Chembiochem: a European journal of chemical biology · 2026-04-28An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.Open Access CRIS of the University of Bern · 2026-01-21Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA network open · 2026-01-02Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.Addiction (Abingdon, England) · 2025-07-24The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Further education in psychedelic-assisted therapy - experiences from Switzerland.BMC medical education · 2025-03-05Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report.Psychiatry research · 2025-03-01Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.Neuroscience applied · 2025-01-01Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.Frontiers in psychiatry · 2024-01-01Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related TryptaminesChemBioChem · 2022-07-05Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.Psychopharmacology · 2022-06-01Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2022-05-01Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience applied · 2022-01-01P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-12-01Spontaneous and deliberate creative cognition during and after psilocybin exposure.Translational psychiatry · 2021-04-08P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental studyEuropean Neuropsychopharmacology · 2021-02-25MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogensNeuropsychopharmacology · 2020-11-19Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2020-11-01P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective stateEuropean Neuropsychopharmacology · 2020-01-28Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-01-13Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.Chembiochem: a European journal of chemical biology · 2019-11-18Production Options for Psilocybin: Making of the Magic.Chemistry (Weinheim an der Bergstrasse, Germany) · 2019-01-18Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot studyMatters · 2019-01-01Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication.Chembiochem: a European journal of chemical biology · 2018-10-18Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.Chemistry (Weinheim an der Bergstrasse, Germany) · 2018-07-17Enzymatic Synthesis of Psilocybin.Angewandte Chemie (International ed. in English) · 2017-09-25Enzymatische Synthese von PsilocybinAngewandte Chemie · 2017-08-01Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.Journal of psychopharmacology (Oxford, England) · 2011-11-01Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-19GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine · 2009-04-01Effects of varied doses of psilocybin on time interval reproduction in human subjects.Neuroscience letters · 2008-04-11Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.Psychopharmacology · 2007-12-01Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of cognitive neuroscience · 2005-10-01Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2005-06-01Psilocybin impairs high-level but not low-level motion perception.Neuroreport · 2004-08-26Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.Psychopharmacology · 2004-03-01The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosisEuropean Neuropsychopharmacology · 2003-10-01A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicitySocial Neuroscience · 2003-01-01Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in manJournal of Pharmaceutical and Biomedical Analysis · 2002-09-0111C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formationJournal of Labelled Compounds and Radiopharmaceuticals · 1998-07-01Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in manPharmaceutica Acta Helvetiae · 1997-06-01